{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:22:54Z","timestamp":1792657374586,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL089405"],"award-info":[{"award-number":["R01 HL089405"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL115265"],"award-info":[{"award-number":["R01 HL115265"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0262-8","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T19:37:06Z","timestamp":1438803426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Youfang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Tina","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shougang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangjian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting C","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"262_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2337\/diab.23.2.105","volume":"23","author":"MJ Garcia","year":"1974","unstructured":"Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23:105\u2013111","journal-title":"Diabetes"},{"key":"262_CR2","doi-asserted-by":"crossref","unstructured":"(1999) Diabetes mellitus. A major risk factor for cardiovascular disease: a joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association., Circulation 100:1132\u20133","DOI":"10.1161\/01.CIR.100.10.1132"},{"key":"262_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1475-2840-12-90","volume":"12","author":"TC Zhao","year":"2013","unstructured":"Zhao TC (2013) Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection. Cardiovasc Diabetol 12:90","journal-title":"Cardiovasc Diabetol"},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595\u2013602","journal-title":"Am J Cardiol"},{"key":"262_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/00004872-200109000-00021","volume":"19","author":"S Carugo","year":"2001","unstructured":"Carugo S, Giannattasio C, Calchera I, Paleari F, Gorgoglione MG, Grappiolo A et al (2001) Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J Hypertens 19:1675\u20131680","journal-title":"J Hypertens"},{"key":"262_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.105.578278","volume":"113","author":"S Itoh","year":"2006","unstructured":"Itoh S, Ding B, Shishido T, Lerner-Marmarosh N, Wang N, Maekawa N et al (2006) Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium. Circulation 113:1787\u20131798","journal-title":"Circulation"},{"key":"262_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2337\/db06-0907","volume":"56","author":"ER Gross","year":"2007","unstructured":"Gross ER, Hsu AK, Gross GJ (2007) Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 56:127\u2013136","journal-title":"Diabetes"},{"key":"262_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1463-1326.2011.01369.x","volume":"13","author":"ND Roe","year":"2011","unstructured":"Roe ND, Thomas DP, Ren J (2011) Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes Obes Metab 13:465\u2013473","journal-title":"Diabetes Obes Metab"},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diabetes.50.6.1414","volume":"50","author":"J Kajstura","year":"2001","unstructured":"Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS et al (2001) IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50:1414\u20131424","journal-title":"Diabetes"},{"key":"262_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00395-008-0715-2","volume":"103","author":"S Van Linthout","year":"2008","unstructured":"Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N et al (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103:319\u2013327","journal-title":"Basic Res Cardiol"},{"key":"262_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0735-1097(03)00509-6","volume":"42","author":"T Shiomi","year":"2003","unstructured":"Shiomi T, Matsusaka H, Hayashidani S, Suematsu N, Wen J, Kubota T et al (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42:165\u2013172","journal-title":"J Am Coll Cardiol"},{"key":"262_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jacc.2011.09.071","volume":"59","author":"B Dong","year":"2012","unstructured":"Dong B, Yu QT, Dai HY, Gao YY, Zhou ZL, Zhang L et al (2012) Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J Am Coll Cardiol 59:739\u2013747","journal-title":"J Am Coll Cardiol"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)00118-5","volume":"103","author":"P Cheung","year":"2000","unstructured":"Cheung P, Allis CD, Sassone-Corsi P (2000) Signaling to chromatin through histone modifications. Cell 103:263\u2013271","journal-title":"Cell"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41\u201345","journal-title":"Nature"},{"key":"262_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251\u2013260","journal-title":"Nature"},{"key":"262_CR16","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1074\/mcp.M113.028332","volume":"12","author":"D Wang","year":"2013","unstructured":"Wang D, Fang C, Zong NC, Liem DA, Cadeiras M, Scruggs SB et al (2013) Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics 12:3793\u20133802","journal-title":"Mol Cell Proteomics"},{"key":"262_CR17","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","volume":"113","author":"Y Kong","year":"2006","unstructured":"Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN et al (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:2579\u20132588","journal-title":"Circulation"},{"key":"262_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32\u201342","journal-title":"Nat Rev Genet"},{"key":"262_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","volume":"113","author":"HJ Kee","year":"2006","unstructured":"Kee HJ, Sohn IS, Nam KI, Park JE, Qian YR, Yin Z et al (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113:51\u201359","journal-title":"Circulation"},{"key":"262_CR20","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1096\/fj.08-108548","volume":"22","author":"A Granger","year":"2008","unstructured":"Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T et al (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22:3549\u20133560","journal-title":"FASEB J"},{"key":"262_CR21","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1016\/j.ijcard.2013.07.111","volume":"168","author":"YH Kao","year":"2013","unstructured":"Kao YH, Liou JP, Chung CC, Lien GS, Kuo CC, Chen SA et al (2013) Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. Int J Cardiol 168:4178\u20134183","journal-title":"Int J Cardiol"},{"key":"262_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.114.303429","volume":"114","author":"GH Eom","year":"2014","unstructured":"Eom GH, Nam YS, Oh JG, Choe N, Min HK, Yoo EK et al (2014) Regulation of acetylation of histone deacetylase 2 by p300\/CBP-associated factor\/histone deacetylase 5 in the development of cardiac hypertrophy. Circ Res 114:1133\u20131143","journal-title":"Circ Res"},{"key":"262_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/jpet.111.189910","volume":"341","author":"L Zhang","year":"2012","unstructured":"Zhang L, Qin X, Zhao Y, Fast L, Zhuang S, Liu P et al (2012) Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther 341:285\u2013293","journal-title":"J Pharmacol Exp Ther"},{"key":"262_CR24","doi-asserted-by":"publisher","first-page":"H2154","DOI":"10.1152\/ajpheart.01015.2009","volume":"298","author":"LX Zhang","year":"2010","unstructured":"Zhang LX, Zhao Y, Cheng G, Guo TL, Chin YE, Liu PY et al (2010) Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am J Physiol Heart Circ Physiol 298:H2154\u2013H2163","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"262_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","volume":"76","author":"TC Zhao","year":"2007","unstructured":"Zhao TC, Cheng G, Zhang LX, Tseng YT, Padbury JF (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76:473\u2013481","journal-title":"Cardiovasc Res"},{"key":"262_CR26","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1002\/jcb.23251","volume":"112","author":"HP Chen","year":"2011","unstructured":"Chen HP, Denicola M, Qin X, Zhao Y, Zhang L, Long XL et al (2011) HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway. J Cell Biochem 112:3246\u20133255","journal-title":"J Cell Biochem"},{"key":"262_CR27","doi-asserted-by":"publisher","first-page":"39338","DOI":"10.1074\/jbc.M112.379115","volume":"287","author":"L Zhang","year":"2012","unstructured":"Zhang L, Chen B, Zhao Y, Dubielecka PM, Wei L, Qin GJ et al (2012) Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. J Biol Chem 287:39338\u201339348","journal-title":"J Biol Chem"},{"key":"262_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1475-2840-12-101","volume":"12","author":"EJ Cox","year":"2013","unstructured":"Cox EJ, Marsh SA (2013) Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A\/HDAC1\/2 complex in the heart. Cardiovasc Diabetol 12:101","journal-title":"Cardiovasc Diabetol"},{"key":"262_CR29","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.yexcr.2010.07.004","volume":"316","author":"XY Yu","year":"2010","unstructured":"Yu XY, Geng YJ, Liang JL, Lin QX, Lin SG, Zhang S et al (2010) High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Exp Cell Res 316:2903\u20132909","journal-title":"Exp Cell Res"},{"key":"262_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1291\/hypres.30.439","volume":"30","author":"H Tsutsui","year":"2007","unstructured":"Tsutsui H, Matsushima S, Kinugawa S, Ide T, Inoue N, Ohta Y et al (2007) Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Hypertens Res 30:439\u2013449","journal-title":"Hypertens Res"},{"key":"262_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2119\/molmed.2011.00021","volume":"17","author":"DP Christensen","year":"2011","unstructured":"Christensen DP, Dahllof M, Lundh M, Rasmussen DN, Nielsen MD, Billestrup N et al (2011) Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol Med 17:378\u2013390","journal-title":"Mol Med"},{"key":"262_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2014.01.063","volume":"728","author":"BM Patel","year":"2014","unstructured":"Patel BM, Raghunathan S, Porwal U (2014) Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus. Eur J Pharmacol 728:128\u2013134","journal-title":"Eur J Pharmacol"},{"key":"262_CR33","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.110.223552","volume":"107","author":"ME Cooper","year":"2010","unstructured":"Cooper ME, El-Osta A (2010) Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107:1403\u20131413","journal-title":"Circ Res"},{"key":"262_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.carpath.2012.07.004","volume":"22","author":"M Asrih","year":"2013","unstructured":"Asrih M, Steffens S (2013) Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc Pathol 22:117\u2013125","journal-title":"Cardiovasc Pathol"},{"key":"262_CR35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","volume":"60","author":"TJ Regan","year":"1977","unstructured":"Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B (1977) Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60:884\u2013899","journal-title":"J Clin Invest"},{"key":"262_CR36","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00125-008-1044-6","volume":"51","author":"MN Busche","year":"2008","unstructured":"Busche MN, Walsh MC, McMullen ME, Guikema BJ, Stahl GL (2008) Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model ofdiabetes. Diabetologia 51:1544\u20131551","journal-title":"Diabetologia"},{"key":"262_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/jmcc.2001.1504","volume":"34","author":"ME Young","year":"2002","unstructured":"Young ME, Wilson CR, Razeghi P, Guthrie PH, Taegtmeyer H (2002) Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol 34:223\u2013231","journal-title":"J Mol Cell Cardiol"},{"key":"262_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S1071-9164(99)91337-4","volume":"5","author":"BD Hoit","year":"1999","unstructured":"Hoit BD, Castro C, Bultron G, Knight S, Matlib MA (1999) Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail 5:324\u2013333","journal-title":"J Card Fail"},{"key":"262_CR39","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M et al (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509\u20131517","journal-title":"Diabetes"},{"key":"262_CR40","doi-asserted-by":"publisher","first-page":"C358","DOI":"10.1152\/ajpcell.00187.2013","volume":"307","author":"LX Zhang","year":"2014","unstructured":"Zhang LX, DeNicola M, Qin X, Du J, Ma J, Zhao TY et al (2014) Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs. Am J Physiol Cell Physiol 307:C358\u2013C372","journal-title":"Am J Physiol Cell Physiol"},{"key":"262_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","volume":"110","author":"CL Zhang","year":"2002","unstructured":"Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479\u2013488","journal-title":"Cell"},{"key":"262_CR42","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1161\/CIRCULATIONAHA.108.824243","volume":"119","author":"W Lieb","year":"2009","unstructured":"Lieb W, Xanthakis V, Sullivan LM, Aragam J, Pencina MJ, Larson MG et al (2009) Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham offspring study. Circulation 119:3085\u20133092","journal-title":"Circulation"},{"key":"262_CR43","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","volume":"105","author":"H Taegtmeyer","year":"2002","unstructured":"Taegtmeyer H, McNulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 105:1727\u20131733","journal-title":"Circulation"},{"key":"262_CR44","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.2337\/db10-1333","volume":"60","author":"Y Li","year":"2011","unstructured":"Li Y, Ma J, Zhu H, Singh M, Hill D, Greer PA et al (2011) Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes. Diabetes 60:2985\u20132994","journal-title":"Diabetes"},{"key":"262_CR45","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1007\/s00125-004-1572-7","volume":"47","author":"J Bojunga","year":"2004","unstructured":"Bojunga J, Nowak D, Mitrou PS, Hoelzer D, Zeuzem S, Chow KU (2004) Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia 47:2072\u20132080","journal-title":"Diabetologia"},{"key":"262_CR46","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2337\/db08-0617","volume":"58","author":"E Shen","year":"2009","unstructured":"Shen E, Li Y, Li Y, Shan L, Zhu H, Feng Q et al (2009) Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58:2386\u20132395","journal-title":"Diabetes"},{"key":"262_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/CIRCHEARTFAILURE.111.961565","volume":"5","author":"H Nakamura","year":"2012","unstructured":"Nakamura H, Matoba S, Iwai-Kanai E, Kimata M, Hoshino A, Nakaoka M et al (2012) p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation. Circ Heart Fail 5:106\u2013115","journal-title":"Circ Heart Fail"},{"key":"262_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ijcard.2012.09.080","volume":"168","author":"WW Kuo","year":"2013","unstructured":"Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH, Chen LM (2013) Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK\/NF\u03baB signaling via attenuating ROS generation. Int J Cardiol 168:270\u2013280","journal-title":"Int J Cardiol"},{"key":"262_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1475-2840-13-100","volume":"13","author":"S Zhang","year":"2014","unstructured":"Zhang S, Liu H, Amarsingh GV, Cheung CC, Hogl S, Narayanan U et al (2014) Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation. Cardiovasc Diabetol 13:100","journal-title":"Cardiovasc Diabetol"},{"key":"262_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1152\/physrev.1992.72.2.369","volume":"72","author":"O Hudlicka","year":"1992","unstructured":"Hudlicka O, Brown M, Egginton S (1992) Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72:369\u2013417","journal-title":"Physiol Rev"},{"key":"262_CR51","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.109.872481","volume":"121","author":"SM Samuel","year":"2010","unstructured":"Samuel SM, Thirunavukkarasu M, Penumathsa SV, Koneru S, Zhan L, Maulik G et al (2010) Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 121:1244\u20131255","journal-title":"Circulation"},{"key":"262_CR52","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1590\/S1807-59322011000800019","volume":"66","author":"M Khazaei","year":"2011","unstructured":"Khazaei M, Fallahzadeh AR, Sharifi MR, Afsharmoghaddam N, Javanmard SH, Salehi E (2011) Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male rats. Clinics (Sao Paulo) 66:1419\u20131424","journal-title":"Clinics (Sao Paulo)"},{"key":"262_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0925-4439(94)90007-8","volume":"1225","author":"H Kainulainen","year":"1994","unstructured":"Kainulainen H, Breiner M, Schurmann A, Marttinen A, Virjo A, Joost HG (1994) In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta 1225:275\u2013282","journal-title":"Biochim Biophys Acta"},{"key":"262_CR54","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1124\/jpet.106.100982","volume":"317","author":"T Zhao","year":"2006","unstructured":"Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT et al (2006) Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther 317:1106\u20131113","journal-title":"J Pharmacol Exp Ther"},{"key":"262_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-014-0118-7","volume":"13","author":"C Marciniak","year":"2014","unstructured":"Marciniak C, Marechal X, Montaigne D, Neviere R, Lancel S (2014) Cardiac contractile function and mitochondrial respiration in diabetes-related mouse models. Cardiovasc Diabetol 13:118","journal-title":"Cardiovasc Diabetol"},{"key":"262_CR56","doi-asserted-by":"publisher","first-page":"E630","DOI":"10.1152\/ajpendo.00109.2014","volume":"307","author":"M DeNicola","year":"2014","unstructured":"DeNicola M, Du J, Wang Z, Yano N, Zhang L, Wang Y et al (2014) Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium. Am J Physiol Endocrinol Metab 307:E630\u2013E643","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"262_CR57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature13596","volume":"514","author":"P Han","year":"2014","unstructured":"Han P, Li W, Lin CH, Yang J, Shang C, Nurnberg ST et al (2014) A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514:102\u2013106","journal-title":"Nature"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-015-0262-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0262-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T12:34:15Z","timestamp":1589459655000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-015-0262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0262-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]},"assertion":[{"value":"6 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}